Aetna (AET) Stock Rating Lowered by Morgan Stanley

Aetna (NYSE:AET) was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating in a research report issued to clients and investors on Wednesday, December 20th, MarketBeat Ratings reports. They currently have a $179.00 price objective on the stock. Morgan Stanley’s target price indicates a potential downside of 2.82% from the stock’s current price.

A number of other equities analysts also recently commented on the stock. Argus reaffirmed a “buy” rating and issued a $185.00 price objective (up previously from $165.00) on shares of Aetna in a report on Tuesday, September 12th. Zacks Investment Research downgraded shares of Aetna from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. Jefferies Group lifted their price objective on shares of Aetna from $163.00 to $165.00 and gave the stock a “hold” rating in a report on Friday, October 13th. BMO Capital Markets initiated coverage on shares of Aetna in a report on Monday, October 16th. They issued a “market perform” rating and a $175.00 price objective for the company. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $175.00 price target on shares of Aetna in a report on Monday, October 23rd. Twelve investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $172.64.

Aetna (AET) traded down $0.01 during midday trading on Wednesday, reaching $184.20. 2,413,600 shares of the company traded hands, compared to its average volume of 4,180,000. Aetna has a 52-week low of $116.04 and a 52-week high of $192.37. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.53 and a quick ratio of 0.53. The stock has a market capitalization of $60,070.00, a price-to-earnings ratio of 34.05, a price-to-earnings-growth ratio of 1.64 and a beta of 0.61.

Aetna (NYSE:AET) last posted its quarterly earnings data on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.06 by $0.39. The company had revenue of $14.99 billion for the quarter, compared to analyst estimates of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The business’s quarterly revenue was down 5.0% on a year-over-year basis. During the same quarter last year, the firm posted $2.07 earnings per share. sell-side analysts anticipate that Aetna will post 9.78 earnings per share for the current fiscal year.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. KAMES CAPITAL plc raised its holdings in Aetna by 22.6% during the 4th quarter. KAMES CAPITAL plc now owns 265,793 shares of the company’s stock worth $48,008,000 after buying an additional 49,077 shares during the period. Milestone Resources Group Ltd purchased a new position in Aetna during the 4th quarter valued at about $35,385,000. Prudential Financial Inc. grew its stake in Aetna by 3.6% during the 3rd quarter. Prudential Financial Inc. now owns 1,089,269 shares of the company’s stock valued at $173,205,000 after acquiring an additional 38,223 shares in the last quarter. Parametric Portfolio Associates LLC grew its stake in Aetna by 3.3% during the 3rd quarter. Parametric Portfolio Associates LLC now owns 1,124,251 shares of the company’s stock valued at $178,767,000 after acquiring an additional 36,129 shares in the last quarter. Finally, AXA grew its stake in Aetna by 16.6% during the 3rd quarter. AXA now owns 274,863 shares of the company’s stock valued at $43,706,000 after acquiring an additional 39,125 shares in the last quarter. Hedge funds and other institutional investors own 87.80% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This report was reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://stocknewstimes.com/2018/01/12/aetna-aet-lowered-to-equal-weight-at-morgan-stanley.html.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Analyst Recommendations for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply